Search

everythinglearnresearchcommunity

for

Search:↓

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Pumpkin seed oil may improve prostate health, bladder control, and hair growth in men.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Silver nanoparticles from Mitracarpus scaber protect the liver and reduce prostate enlargement.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Male pattern baldness does not cause an increased risk of prostate cancer.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Testosterone significantly affects urination differences between male and female mice.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Saw palmetto is not proven to improve urinary flow, prostate size, or hair loss.

The models can help find better inhibitors for conditions like baldness and prostate disorders.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.